SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-192133
Filing Date
2018-06-14
Accepted
2018-06-14 07:30:05
Documents
4
Period of Report
2018-06-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d609470d8k.htm 8-K 15273
2 EX-99.1 d609470dex991.htm EX-99.1 19038
3 GRAPHIC g609470dsp1.jpg GRAPHIC 2526
4 GRAPHIC g609470dsp1a.jpg GRAPHIC 3406
  Complete submission text file 0001193125-18-192133.txt   43816
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 18898061
SIC: 2834 Pharmaceutical Preparations